Navigation Links
BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
Date:4/26/2008

that can cause AIDS) and are not taking medicines for HIV at the same time, some HIV treatments that they may take in the future may be less likely to work. People are advised to get an HIV test before starting to take BARACLUDE and anytime that there is a chance they were exposed to HIV. BARACLUDE will not help HIV infection.

In some people, hepatitis B symptoms may get worse or become very serious when they stop taking BARACLUDE. People should not stop BARACLUDE without talking to their healthcare provider. Healthcare providers will need to follow their patients and do blood tests to check the liver when BARACLUDE is stopped. People should tell their healthcare provider if they have or develop kidney problems because their healthcare provider may want to do tests to see if a lower dose is needed.

Because BARACLUDE is removed from the body through the kidneys, a dose adjustment may be required. Healthcare providers may want to perform tests to determine whether a patient needs a lower dose or should take BARACLUDE less often than once a day.

It is not known if BARACLUDE(R) (entecavir) is safe to use during pregnancy. It is not known if BARACLUDE helps to prevent a pregnant mother from passing HBV to her baby. A pregnant woman and her healthcare provider will need to decide if BARACLUDE is right for her. A woman should not breastfeed if she is taking BARACLUDE.

People should discuss with their healthcare provider all prescription and non-prescription medicines, vitamins, herbal supplements, and other health preparations they are taking or plan to take. BARACLUDE may interact with medicines that leave the body through the kidneys. The safety and effectiveness of BARACLUDE in liver transplant recipients is unknown. The most common side effects of BARACLUDE in clinical studies were headache, tiredness, dizziness, and nausea.

This list of side effects is not complete at this time because BARACLUDE is still under study. People should re
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Many Heart Attack Patients Dont Get Best Emergency Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Warner Chilcott plc (Nasdaq: ... Warner Chilcott Corporation (the "Company") has commenced a ... to the conditions set forth in the Company,s ... December 15, 2009 (the "Offer to Purchase"), for ... subordinated notes due 2015 (the "Notes"). ,, The ...
(Date:12/15/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that it will release its ... 2010 after the market close. The Company will host ... 8:30 a.m. (Eastern Time) to discuss the results. ... conference call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can ...
(Date:12/15/2009)... INCLINE VILLAGE, Nev., Dec. 15 PDL BioPharma, ... it has paid the December 15, 2009 special dividend ... shares of PDL as of December 1, 2009. ... ended December 31, 2009 total $2.67 per share. ... regarding the federal tax characteristics of the Company,s 2009 ...
Breaking Medicine Technology:Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6PDL BioPharma Completes December 15 Special Dividend Payment 2ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 1ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 2ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 3ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 4ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 5ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 6ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 7ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 8ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 9ThermoGenesis Reports Fourth Quarter and Fiscal 2009 Results 13955 10Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 1Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 2Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 3Verenium 1 3A12 Reverse Stock Split Takes Effect 13953 4Brain Scans Could Help Spot Schizophrenia Earlier 56674 1Brain Scans Could Help Spot Schizophrenia Earlier 56674 2
... /PRNewswire-FirstCall/ --,Alfacell Corporation's ONCONASE (ranpirnase) has shown ... antibody conjugates for cancer therapy,according to the ... , In a chapter of the text ... research indicating that the,specificity and potency of ...
... Levels in Two Most Common Mutations, CRANBURY, ... a biopharmaceutical company developing small,molecule, orally-administered pharmacological ... human genetic diseases, announced today,that it will ... (isofagomine tartrate, AT2101) for Gaucher disease at,the ...
Other Medicine Technology:Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 2Amicus Therapeutics Presents Preclinical Data from Studies of,Plicera for Gaucher Disease 3
(Date:12/15/2009)... SUMMARY: The U.S. Senate ... and Affordable Care Act that would have helped ... the safe and legal importation of lower priced ... AARP and sponsored by Senators Dorgan, Snowe, McCain, ... helped to bring down the skyrocketing costs of ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
(Date:12/15/2009)... High levels of leptin associated with lower dementia risk, ... High blood levels of leptin, a hormone that regulates ... , "Hopefully, in 10 or 15 years this may ... reduce the risk of Alzheimer,s disease," said senior study ... at Boston University School of Medicine. "Or it may ...
(Date:12/15/2009)... education program will train advocates to be leaders ... Project developed with support from experts in online ... ,, WASHINGTON, Dec. 15 ... are accepting applications for the first-ever "Malaria Griots" ... and educate participants to become leaders in the ...
(Date:12/15/2009)... Dec. 15 The following are the ... for the criminal division, at the Medicare Fraud ... Sebelius. And thank you for the enormous effort ... initiative. ,, Together, our Departments have and ... ,, We,ve made tremendous progress in fighting Medicare ...
Breaking Medicine News(10 mins):Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3
... largest rollouts of Digital Dictation technology within the NHS produces significant ... ... 2009 -- BigHand has today announced that Sheffield Teaching Hospitals NHS ... over 1000 users spanning 5 hospitals on 2 campuses in one ...
... Dr. Elizabeth M. Trinidad, a fellowship trained pediatric neurosurgeon, has joined Neurological ... the New York Tristate area. Dr. Trinidad specialized in the treatment ... spine and is also a Lieutenant Colonel with the United States ... ...
... , Tuesday, January 13, 2009 , 10:00 a.m. Eastern Standard Time ... Queens , NY , Locations of ... by the National Institutes of Health: What: A media telephone ... National Children,s Study. The largest child health study in the ...
... ignored their cost saving suggestionsHARRISBURG, Pa., Jan. 6 ... closing the state,s budget shortfall, SEIU Local 668, the ... Pennsylvania, said they have identified millions of dollars that ... cancel contracts with private contractors for work that can ...
... FARMINGDALE, N.Y., Jan. 6 Dieters craving a ... pounds can now find a refreshing option at ... Integrated Beverage Group, Ltd. (IBG). The company, a ... announced major new relationships with leading distributors, retailers ...
... technologies can create environments that require very little physical ... Nintendo,s Wii Fit can help promote physical rather than ... think there is a great potential to develop ways ... professor and head of the department of kinesiology at ...
Other Medicine News:Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 2Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 3Health News:Neurological Surgery, P.C. of Long Island, NY Announces the Addition of Pediatric Neurosurgeon, Elizabeth M. Trinidad, M.D. 4Health News:Telebriefing: National Children's Study Recruitment Begins 2Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Skinny Dippers(TM), First Zero-Calorie Frozen Dessert, Earns Widespread Retail, Online Distribution 2Health News:Wii Fit a promising tool for all ages 2Health News:Wii Fit a promising tool for all ages 3
Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....
... Nile Virus IgG DxSelect is intended,for ... Nile virus in human,serum. In conjunction ... Virus,IgM Capture DxSelect, the test is ... meningioencephalitis, as an aid in the,presumptive ...
... PachPen uses state-of-the-art waveform analysis ... at a 65MHz rate to ... stores and averages nine measurements ... pen fits comfortably into the ...
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
Medicine Products: